About Continua Process Systems

Continua Process Systems' mission is to develop and apply innovative Process Orchestration Layer (POL) software, and integrated solutions that enable pharmaceutical and biotech manufacturers, and their OEMs to integrally design quality, modularity, flexibility, and real-time materials tracking and traceability into the control of continuous manufacturing processes.

Our unique ContinuousPlant® process automation and data management solutions are specifically designed to provide continuous analysis, control, and data collection of Critical Process Parameter (CPP) variables that directly affect predefined and measured Critical Quality Attributes (CQA). Continua’s integrated solutions enable users to deploy modular, multi-product continuous manufacturing lines to produce APIs, biologics, and drug products more predictably, efficiently, and of better quality than traditional batch manufacturing methods.

Continua Process Systems' systems engineers have extensive knowledge and experience with developing and implementing process control, Process Analytical Technology (PAT), materials tracking and traceability, and manufacturing execution systems (MES). We employ data management, PAT, and MES engineers to seamlessly integrate this software into our continuous manufacturing solutions. This combination of process automation, and data management expertise coupled with our life sciences project implementation experience enables Continua to take a holistic approach on how best to solve your process control and data management challenges.

Continua Process Systems is an active member of the Engineering Research Center (ERC) for Structured Organic Particulate Systems (ERC-SOPS) at the Rutgers University School of Engineering in New Brunswick, NJ. Users can contract with C-SOPS for access to their continuous manufacturing facilities and cross-disciplinary team of scientists, engineers, consultants, and industry leaders who are available to support the development of science-based, advanced manufacturing processes from initial concept to qualification.

Continua’s goal is to become a valued partner and provider of innovative process automation and data management solutions to the pharmaceutical and biotech industry as it strives to produce safer, more effective, and higher quality drug products better, faster and more economically.

Terry Spaeth
Co-Founder, Continua Process Systems

Paul Brodbeck
Chief Technologist & Co-Founder, Continua Process Systems

Brian Sauerborn
Lead Engineer, Continua Process Systems

Featured News/Case Study

Emerson Receives 2021 IoT Breakthrough Award for ‘Analytics Platform of the Year’

Wednesday 01.20.21
ST. LOUIS – Emerson (NYSE:EMR), a global automation technology and software company, has received the “IoT Analytics Platform of the Year” award for its Plantweb Optics™ Analytics software. The honor,
... Read More... Read More

See All News/Case Studies >>